Skip to main content
Figure 1 | Molecular Cancer

Figure 1

From: Constitutively overexpressed 21 kDa protein in Hodgkin lymphoma and aggressive non-Hodgkin lymphomas identified as cytochrome B5b (CYB5B)

Figure 1

Immunoprecipitation of the 21 kDa protein. Panel A: Western-blot analysis of immunoprecipitated 21 kDa protein (probed with anti-R23.1 MAb). Lane 1: MW = Bio-Rad Kaleidoscope molecular weight markers. Lane 2: Protein immunoprecipitated by R23.1. Lane 3: protein immunoprecipitated by R24.1. Both anti-R23.1 and anti-R24.1 MAbs precipitated a protein of ~21 kDa. Panel B: Immunoblots (probed with anti-R23.1 MAb) of subcellular fractions of cell lysates after separation of biotin-labelled surface proteins on NeutrAvidin agarose beads. Lanes 1-3: Unlabelled controls (no biotin label added to surface proteins). Lanes 4-6: Surface biotin labelled protein samples. Lane 1 and 4: Total cell lysate not further fractionated on NeutrAvidin agarose beads. Lanes 2 and 5: Proteins (cytosolic) not bound to the NeutrAvidin agarose beads. Lane 6: Cell surface biotin-labelled proteins eluted from the avidin-beads. The results show that Jurkat and L428 cells contain the protein recognised by anti-R23.1 MAb in the cytosolic fraction (Lane 5) and but only L428 cells express the protein on the cell surface (Lane 6). No protein was detected in eluted fractions from avidin beads in the absence of surface biotin labelling (Lane 3), indicating no evidence of non-specific binding of unlabelled proteins to avidin beads.

Back to article page